Location History:
- Horsham, GB (2003 - 2006)
- Kraainem, BE (2010)
Company Filing History:
Years Active: 2003-2010
Title: Innovations of Trevor John Howe
Introduction
Trevor John Howe is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as CCR3-receptor antagonists. With a total of 3 patents to his name, Howe's work is recognized for its potential in treating various medical conditions.
Latest Patents
Howe's latest patents include innovative compounds that have shown promise in the pharmaceutical industry. One of his patents focuses on pyrrolidine derivatives that act as CCR3-receptor antagonists. These compounds, described in the patent, are useful for treating conditions mediated by CCR3. The patent also details pharmaceutical compositions containing these compounds and the processes for their preparation. Another significant patent involves N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides, which serve as CCR3 receptor antagonists. This patent outlines compounds that are beneficial as pharmaceuticals, showcasing Howe's expertise in medicinal chemistry.
Career Highlights
Trevor John Howe is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative research and development in the pharmaceutical sector. Howe's contributions have been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Howe has collaborated with several talented individuals, including Gurdip Bhalay and Darren Mark Le Grand. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Trevor John Howe's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.